Serum Institute of India launches first made-in-India HPV vaccine for cervical cancer

Jan 24, 2023

The indigenously developed vaccine, "CERVAVAC" was announced for the prevention of cervical cancer.

SII launches India's first fully indigenously developed pneumococcal vaccine

Dec 28, 2020

Pune (Maharashtra) [India], December 28 : Serum Institute of India, the largest vaccine manufacturer in the world by doses, announces the launch of India's...

Nepal gives emergency approval to India's Covaxin

Mar 20, 2021

Kathmandu [Nepal], March 20 : Nepal has approved India's indigenously developed COVID-19 vaccine Covaxin for emergency use.

COVID-19 vaccine Covaxin now universal vaccine for adults, children: Bharat Biotech

Jan 13, 2022

New Delhi [India], January 14 : Hyderabad-based vaccine manufacturer Bharat Biotech on Thursday announced that its indigenously developed COVID-19 vaccine Coavaxin is now a...

India provides 1,00,000 doses of Covaxin to Paraguay

Mar 29, 2021

Asuncion [Paraguay], March 30 : Paraguay on Monday received a shipment of 1,00,000 doses of India's indigenously developed Covaxin vaccine.

SEC to discuss India's first indigenously developed vaccine against cervical cancer

Jun 15, 2022

New Delhi [India] June 15 : The first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer by the Serum Institute of India...